MedTrace Logo

Nutritional Supplementation With Agmatine Sulfate During Small Fiber Neuropathy

NCT01524666 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2018-02-28

No results posted yet for this study

Summary

This is a nonblinded Case-only study that evaluates the effects of Agmatine Sulfate on small fiber peripheral neuropathy. Patients will be started on Agmatine sulfate (a metabolite of Arginine) and monitored for two months. Improvement will be noted on their response to the Neuropathic Pain Questionnaire. Additionally the investigators will note improvement by performing autonomic function testing at the beginning and end of the study.

Conditions

Sponsors & Collaborators

  • JFK Medical Center

    lead OTHER

Principal Investigators

  • Michael Rosenberg, M.D. · JFK Medical Center

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2018-10-31
Completion
2018-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01524666 on ClinicalTrials.gov